Back to
BALYASNY ASSET MANAGEMENT L.P.CMCMTA
CMCMTA2 quarters
Position history for
BALYASNY ASSET MANAGEMENT L.P.'s holdings in Clementia Pharmaceuticals Inc.
BALYASNY ASSET MANAGEMENT L.P. previously held 0 shares of CMTA (Clementia Pharmaceuticals Inc.), worth $0 as of 2019-Q2.
Final Value
$0
Final Shares
0
Total Value Change
-$5.1M
Total Shares Change
-196,451
Quarter-by-Quarter History
Other major holders of CMTA: BAKER BROS. ADVISORS LP, Alyeska Investment Group, L.P., TUDOR INVESTMENT CORP ET AL, DRIEHAUS CAPITAL MANAGEMENT LLC, FEDERATED HERMES, INC.